| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Director
7 companies
Fletcher Aaron G.L. is a Director at Cue Biopharma, Inc. with holdings across 7 companies. Recent SEC Form 4 filings include 15 buys and 1 sell.
Estimated insider holdings value: $35.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2022 | INAB In8bio, Inc. | Director, 10% Owner | Buy | 50,000 | $1.93 | $96,500.00 | +1.1% | -20.2% | -42.4% | |
| Aug 16, 2022 | INAB In8bio, Inc. | Director, 10% Owner | Buy | 1,773,684 | $1.90 | $3,369,999.60 | +69.3% | -19.6% | -37.0% | |
| May 24, 2022 | CUE Cue Biopharma, Inc. | Director | Buy | 205,000 | $3.47 | $711,700.00 | +12.7% | -8.4% | +16.5% | |
| Mar 31, 2022 | CUE Cue Biopharma, Inc. | Director | Buy | 735,000 | $4.76 | $3,498,600.00 | New | -41.8% | -26.8% | |
| Oct 13, 2021 | CGTX Cognition Therapeutics Inc | Director | Buy | 190,000 | $12.00 | $2,280,000.00 | +22.2% | -43.4% | -85.1% | |
| Oct 13, 2021 | CGTX Cognition Therapeutics Inc | Director | Sell | 90 | $12.00 | $1,083.36 | - | -43.4% | -85.1% | |
| Nov 24, 2020 | CUE Cue Biopharma, Inc. | Director | Buy | 6,548 | $12.64 | $82,775.89 | +4.1% | - | - | |
| Jun 24, 2020 | CUE Cue Biopharma, Inc. | Director | Buy | 7,500 | $24.88 | $186,571.80 | +2.4% | - | - |